Liquiritin ameliorates painful diabetic neuropathy in SD rats by inhibiting NLRP3-MMP-9-mediated reversal of aquaporin-4 polarity in the glymphatic system
Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential...
Saved in:
Published in | Frontiers in pharmacology Vol. 15; p. 1436146 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
04.09.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential role and mechanism of liquiritin in PDN treatment remain uncertain.
This study established a rat model of PDN using a combination of low-dose Streptozotocin (STZ) and a high-fat, high-sugar diet. Rats were treated with liquiritin and MCC950 (an NLRP3 inhibitor). We monitored fasting blood glucose, body weight, and mechanical allodynia periodically. The glymphatic system's clearance function was evaluated using Magnetic Resonance Imaging (MRI), and changes in proteins including NLRP3, MMP-9, and AQP4 were detected through immunofluorescence and Western blot techniques.
The rats with painful diabetic neuropathy (PDN) demonstrated several physiological changes, including heightened mechanical allodynia, compromised clearance function within the spinal glymphatic system, altered distribution of AQP4, increased count of activated astrocytes, elevated expression levels of NLRP3 and MMP-9, and decreased expression of AQP4. However, following treatment with liquiritin and MCC950, these rats exhibited notable improvements.
Liquiritin may promote the restoration of AQP4 polarity by inhibiting NLRP3 and MMP-9, thereby enhancing the clearance functions of the spinal cord glymphatic system in PDN rats, alleviating the progression of PDN. |
---|---|
AbstractList | Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential role and mechanism of liquiritin in PDN treatment remain uncertain.BackgroundDespite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential role and mechanism of liquiritin in PDN treatment remain uncertain.This study established a rat model of PDN using a combination of low-dose Streptozotocin (STZ) and a high-fat, high-sugar diet. Rats were treated with liquiritin and MCC950 (an NLRP3 inhibitor). We monitored fasting blood glucose, body weight, and mechanical allodynia periodically. The glymphatic system's clearance function was evaluated using Magnetic Resonance Imaging (MRI), and changes in proteins including NLRP3, MMP-9, and AQP4 were detected through immunofluorescence and Western blot techniques.MethodsThis study established a rat model of PDN using a combination of low-dose Streptozotocin (STZ) and a high-fat, high-sugar diet. Rats were treated with liquiritin and MCC950 (an NLRP3 inhibitor). We monitored fasting blood glucose, body weight, and mechanical allodynia periodically. The glymphatic system's clearance function was evaluated using Magnetic Resonance Imaging (MRI), and changes in proteins including NLRP3, MMP-9, and AQP4 were detected through immunofluorescence and Western blot techniques.The rats with painful diabetic neuropathy (PDN) demonstrated several physiological changes, including heightened mechanical allodynia, compromised clearance function within the spinal glymphatic system, altered distribution of AQP4, increased count of activated astrocytes, elevated expression levels of NLRP3 and MMP-9, and decreased expression of AQP4. However, following treatment with liquiritin and MCC950, these rats exhibited notable improvements.ResultsThe rats with painful diabetic neuropathy (PDN) demonstrated several physiological changes, including heightened mechanical allodynia, compromised clearance function within the spinal glymphatic system, altered distribution of AQP4, increased count of activated astrocytes, elevated expression levels of NLRP3 and MMP-9, and decreased expression of AQP4. However, following treatment with liquiritin and MCC950, these rats exhibited notable improvements.Liquiritin may promote the restoration of AQP4 polarity by inhibiting NLRP3 and MMP-9, thereby enhancing the clearance functions of the spinal cord glymphatic system in PDN rats, alleviating the progression of PDN.ConclusionLiquiritin may promote the restoration of AQP4 polarity by inhibiting NLRP3 and MMP-9, thereby enhancing the clearance functions of the spinal cord glymphatic system in PDN rats, alleviating the progression of PDN. Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential role and mechanism of liquiritin in PDN treatment remain uncertain. This study established a rat model of PDN using a combination of low-dose Streptozotocin (STZ) and a high-fat, high-sugar diet. Rats were treated with liquiritin and MCC950 (an NLRP3 inhibitor). We monitored fasting blood glucose, body weight, and mechanical allodynia periodically. The glymphatic system's clearance function was evaluated using Magnetic Resonance Imaging (MRI), and changes in proteins including NLRP3, MMP-9, and AQP4 were detected through immunofluorescence and Western blot techniques. The rats with painful diabetic neuropathy (PDN) demonstrated several physiological changes, including heightened mechanical allodynia, compromised clearance function within the spinal glymphatic system, altered distribution of AQP4, increased count of activated astrocytes, elevated expression levels of NLRP3 and MMP-9, and decreased expression of AQP4. However, following treatment with liquiritin and MCC950, these rats exhibited notable improvements. Liquiritin may promote the restoration of AQP4 polarity by inhibiting NLRP3 and MMP-9, thereby enhancing the clearance functions of the spinal cord glymphatic system in PDN rats, alleviating the progression of PDN. Background Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential role and mechanism of liquiritin in PDN treatment remain uncertain. Methods This study established a rat model of PDN using a combination of low-dose Streptozotocin (STZ) and a high-fat, high-sugar diet. Rats were treated with liquiritin and MCC950 (an NLRP3 inhibitor). We monitored fasting blood glucose, body weight, and mechanical allodynia periodically. The glymphatic system’s clearance function was evaluated using Magnetic Resonance Imaging (MRI), and changes in proteins including NLRP3, MMP-9, and AQP4 were detected through immunofluorescence and Western blot techniques. Results The rats with painful diabetic neuropathy (PDN) demonstrated several physiological changes, including heightened mechanical allodynia, compromised clearance function within the spinal glymphatic system, altered distribution of AQP4, increased count of activated astrocytes, elevated expression levels of NLRP3 and MMP-9, and decreased expression of AQP4. However, following treatment with liquiritin and MCC950, these rats exhibited notable improvements. Conclusion Liquiritin may promote the restoration of AQP4 polarity by inhibiting NLRP3 and MMP-9, thereby enhancing the clearance functions of the spinal cord glymphatic system in PDN rats, alleviating the progression of PDN. BackgroundDespite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a significant correlation between the expression and distribution of Aquaporin-4 (AQP4) in the spinal glymphatic system and PDN. However, the potential role and mechanism of liquiritin in PDN treatment remain uncertain.MethodsThis study established a rat model of PDN using a combination of low-dose Streptozotocin (STZ) and a high-fat, high-sugar diet. Rats were treated with liquiritin and MCC950 (an NLRP3 inhibitor). We monitored fasting blood glucose, body weight, and mechanical allodynia periodically. The glymphatic system’s clearance function was evaluated using Magnetic Resonance Imaging (MRI), and changes in proteins including NLRP3, MMP-9, and AQP4 were detected through immunofluorescence and Western blot techniques.ResultsThe rats with painful diabetic neuropathy (PDN) demonstrated several physiological changes, including heightened mechanical allodynia, compromised clearance function within the spinal glymphatic system, altered distribution of AQP4, increased count of activated astrocytes, elevated expression levels of NLRP3 and MMP-9, and decreased expression of AQP4. However, following treatment with liquiritin and MCC950, these rats exhibited notable improvements.ConclusionLiquiritin may promote the restoration of AQP4 polarity by inhibiting NLRP3 and MMP-9, thereby enhancing the clearance functions of the spinal cord glymphatic system in PDN rats, alleviating the progression of PDN. |
Author | Jia, Shuai-Ying Xu, Wen-Mei Yin, Wen-Qin Lin, Jing-Yan Li, Jiang Yan, Wei |
AuthorAffiliation | 1 Department of Anesthesiology , The Affiliated Hospital of North Sichuan Medical College , Nanchong , China 2 Department of Medical Imaging , The Affiliated Hospital of North Sichuan Medical College , Nanchong , China |
AuthorAffiliation_xml | – name: 2 Department of Medical Imaging , The Affiliated Hospital of North Sichuan Medical College , Nanchong , China – name: 1 Department of Anesthesiology , The Affiliated Hospital of North Sichuan Medical College , Nanchong , China |
Author_xml | – sequence: 1 givenname: Shuai-Ying surname: Jia fullname: Jia, Shuai-Ying organization: Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China – sequence: 2 givenname: Wen-Qin surname: Yin fullname: Yin, Wen-Qin organization: Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China – sequence: 3 givenname: Wen-Mei surname: Xu fullname: Xu, Wen-Mei organization: Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China – sequence: 4 givenname: Jiang surname: Li fullname: Li, Jiang organization: Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China – sequence: 5 givenname: Wei surname: Yan fullname: Yan, Wei organization: Department of Medical Imaging, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China – sequence: 6 givenname: Jing-Yan surname: Lin fullname: Lin, Jing-Yan organization: Department of Anesthesiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39295943$$D View this record in MEDLINE/PubMed |
BookMark | eNpVUstu2zAQFIoUzaP5gR4KHnuRS3IpWTwVRdKmAZw26ONMkPTSZiCJMikF8K_0a0s_GiS88DUzuzuY8-KkDz0WxTtGZwCN_OiGtY4zTrmYMQE1E_Wr4ozVNZSyYfzk2fm0uEzpgeYFUkIt3hSnILmspICz4u_CbyYf_eh7ojtsfYh6xEQG7Xs3tWTptcHRW9LjFMOgx_WWZOiva5JxiZjdbe3Njr8i3xc_76G8u7svZdlhpo64JBEfMSbdkuCI3kx6CNH3pSBDaHWuu5cb10hW7bbLM-1qpW0asXtbvHa6TXh53C-KP1-__L76Vi5-3NxefV6UFio6lhZN5fJwrLFIOXW2dgwaqCznEhw2VfaBajSNMWhZzeas4swx2gDUjQCEi-L2oLsM-kEN0Xc6blXQXu0fQlwpHXNbLaq5cWCNtVTwWogaGjdnlhtOl0uZPdVZ69NBa5hMdsBiP0bdvhB9-dP7tVqFR8WYyB1xyAofjgoxbCZMo-p8sti2uscwJQWM1nOouOQZyg9QG0NKEd1THUbVLiRqHxK1C4k6hiST3j_v8InyPxLwD_N-vTg |
Cites_doi | 10.1097/wnr.0000000000001880 10.1358/mf.2009.31.4.1362513 10.1177/0271678x16654702 10.7326/m14-0511 10.2337/dc11-1108 10.1016/j.neuropharm.2024.109907 10.1002/jnr.25104 10.1186/s12987-018-0098-1 10.1080/14728222.2017.1398236 10.3389/fneur.2019.01019 10.1177/44.12.8985139 10.1016/j.biopha.2017.07.167 10.1016/j.jneuroim.2020.577457 10.1016/j.neulet.2023.137164 10.1016/j.heliyon.2023.e13290 10.1016/b978-0-12-386043-9.00001-3 10.3390/biomedicines10092261 10.1038/s41419-020-03178-2 10.1097/shk.0000000000001832 10.1038/nrn1870 10.3389/fphar.2019.01522 10.1016/j.expneurol.2016.05.003 10.1002/dmrr.1225 10.1016/j.neulet.2021.136049 10.1016/j.fitote.2020.104803 10.1007/s00429-013-0629-0 10.1016/j.vascn.2012.04.006 10.3389/fphar.2022.944386 10.1093/brain/awad274 10.1002/ana.24271 10.7554/eLife.40070 10.1016/j.lfs.2021.120062 10.3892/mmr.2017.6786 10.1002/jmri.25168 10.1016/j.jare.2023.03.004 10.1016/j.jneuroim.2013.06.005 10.1016/j.neuroscience.2012.06.002 10.1523/jneurosci.3020-14.2014 10.1186/1742-2094-7-36 10.2147/dddt.S386805 10.1126/scitranslmed.3003748 10.3389/fnana.2020.00017 10.1016/j.diabres.2022.109806 10.1186/s13041-014-0069-7 10.1038/nrn3468 10.1016/j.diabres.2021.109119 10.3390/ijms17101413 10.3389/fnins.2022.926128 10.1007/s11064-015-1581-6 10.3171/2022.4.Jns212945 10.3389/fnmol.2017.00395 10.3389/fphar.2020.00436 10.1111/pedi.13033 10.1172/jci67677 10.1016/j.mcn.2012.02.002 10.1016/j.xphs.2022.03.021 10.1016/j.neuroscience.2016.03.055 10.1002/cpz1.78 10.1083/jcb.153.3.543 10.1523/jneurosci.17-01-00171.1997 10.1371/journal.pone.0163909 10.3892/ijmm.2018.3720 10.1016/j.lfs.2017.05.028 10.1523/jneurosci.1592-13.2013 10.3389/fncel.2019.00572 10.1038/72256 10.1016/0165-0270(94)90144-9 10.1016/j.steroids.2007.12.018 10.1016/j.intimp.2022.108800 10.1186/s12906-016-1048-6 10.3389/fphar.2021.605814 10.7554/eLife.82232 10.3389/fphys.2020.01016 10.1016/j.taap.2021.115468 10.1038/nn.4288 10.3310/rxuo6757 10.1016/j.intimp.2021.108283 10.1002/glia.22319 10.1136/bmjdrc-2020-001847 10.1001/jamaneurol.2016.4370 10.1523/jneurosci.3390-16.2017 10.1038/ncomms4413 10.1007/s13300-019-00695-y 10.1038/s41417-022-00582-y 10.1371/journal.pone.0107022 10.1038/s41419-019-1761-4 10.3389/fphar.2023.1128496 10.1007/s00467-006-0411-0 10.1016/j.lfs.2020.117638 10.1016/j.lfs.2019.02.024 10.1097/j.pain.0000000000001744 10.1007/s00401-009-0558-4 10.3389/fphar.2021.719758 10.1016/j.jcjd.2020.11.011 |
ContentType | Journal Article |
Copyright | Copyright © 2024 Jia, Yin, Xu, Li, Yan and Lin. Copyright © 2024 Jia, Yin, Xu, Li, Yan and Lin. 2024 Jia, Yin, Xu, Li, Yan and Lin |
Copyright_xml | – notice: Copyright © 2024 Jia, Yin, Xu, Li, Yan and Lin. – notice: Copyright © 2024 Jia, Yin, Xu, Li, Yan and Lin. 2024 Jia, Yin, Xu, Li, Yan and Lin |
DBID | NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fphar.2024.1436146 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Jia et al |
EISSN | 1663-9812 |
ExternalDocumentID | oai_doaj_org_article_7bf3cbcc042644638f71c2b20dd9392a 10_3389_fphar_2024_1436146 39295943 |
Genre | Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK EMOBN GROUPED_DOAJ GX1 HYE IAO IEA IHR IHW IPNFZ KQ8 M48 M~E NPM O5R O5S OK1 P2P PGMZT RIG RNS RPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c350t-ceb5f00018ce020fc6f13835c2293fe856630aeb8bbec16171521f108336843e3 |
IEDL.DBID | RPM |
ISSN | 1663-9812 |
IngestDate | Tue Oct 22 15:15:21 EDT 2024 Thu Sep 19 05:32:17 EDT 2024 Sat Oct 26 04:03:12 EDT 2024 Thu Sep 26 20:27:18 EDT 2024 Sat Nov 02 12:19:13 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | aquaporin-4 liquiritin matrix metalloproteinase-9 glymphatic system painful diabetic neuropathy |
Language | English |
License | Copyright © 2024 Jia, Yin, Xu, Li, Yan and Lin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c350t-ceb5f00018ce020fc6f13835c2293fe856630aeb8bbec16171521f108336843e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Idris Long, University of Science Malaysia (USM), Malaysia Edited by: Tzer-Bin Lin, Taipei Medical University, Taiwan Reviewed by: Bin-Nan Wu, Kaohsiung Medical University, Taiwan |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11408323/ |
PMID | 39295943 |
PQID | 3106735292 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_7bf3cbcc042644638f71c2b20dd9392a pubmedcentral_primary_oai_pubmedcentral_nih_gov_11408323 proquest_miscellaneous_3106735292 crossref_primary_10_3389_fphar_2024_1436146 pubmed_primary_39295943 |
PublicationCentury | 2000 |
PublicationDate | 2024-09-04 |
PublicationDateYYYYMMDD | 2024-09-04 |
PublicationDate_xml | – month: 09 year: 2024 text: 2024-09-04 day: 04 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in pharmacology |
PublicationTitleAlternate | Front Pharmacol |
PublicationYear | 2024 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | An (B4) 2021; 9 Hubbard (B22) 2016; 283 Cheng (B9) 2021; 149 Das (B11) 2012; 220 Yin (B86) 2019; 13 Han (B20) 2022; 16 Paschou (B48) 2019; 10 Peng (B49) 2020; 11 Wang (B74); 111 Li (B33) 2018; 42 Manley (B40) 2000; 6 Aronson (B5) 2021; 45 Xian (B79) 2021; 351 Griebeler (B16) 2014; 161 Jessen (B28) 2015; 40 Gylfadottir (B18) 2020; 161 Papadopoulos (B46) 2007; 22 Tesfaye (B64) 2011; 27 Troili (B67) 2020; 14 Zheng (B93); 12 Zhang (B91) 2021; 12 Liu (B37) 2024; 147 Tesfaye (B63) 2022; 26 Thomas (B65) 2016; 11 Yang (B83) 2012; 49 Zhang (B89); 95 Verkman (B68) 2017; 21 Zheng (B94); 416 Amutha (B3) 2021; 22 Wang (B69); 16 Deng (B12) 2014; 9 Aman (B2) 2016; 16 Gomolka (B15) 2023; 12 Kress (B31) 2014; 76 Sun (B59) 2019; 10 Xu (B80) 2023; 34 Buccellato (B6) 2022; 10 Li (B34) 2014; 7 Islam (B27) 2009; 31 Chaplan (B7) 1994; 53 Dai (B10) 2017; 16 Luo (B39) 2019; 10 Wang (B70); 100 Zhang (B90) 2022; 186 Iliff (B26); 33 Iliff (B25) 2012; 4 Wolburg (B77) 2011; 287 Nirogi (B45) 2012; 66 Yao (B85) 2014; 5 Furman (B13) 2021; 1 Nielsen (B44) 1997; 17 Ropero (B51) 2008; 73 Si (B55) 2024; 56 Talbot (B61) 2010; 7 Wang (B71) 2020; 251 Chen (B8) 2022; 13 Iliff (B23) 2014; 34 Liu (B35) 2018; 15 Shang (B54) 2023; 801 Wolburg-Buchholz (B78) 2009; 118 Tang (B62) 2016; 17 Sweeney (B60) 2016; 19 Sun (B58) 2022; 183 Yamaguchi (B81) 2023; 138 Yan (B82) 2016; 326 Ni (B43) 2020; 11 Hellström (B21) 2001; 153 Wang (B75); 30 Starobova (B56) 2020; 11 Abbott (B1) 2011; 34 Zeppenfeld (B87) 2017; 74 Haj-Yasein (B19) 2012; 60 Zychowska (B95) 2013; 262 Wang (B73); 9 Jiang (B29) 2017; 37 Schain (B52) 2017; 37 Liu (B36) 2021; 286 Iliff (B24); 123 Su (B57) 2019; 10 Zhang (B88); 10 Zheng (B92) 2022; 109 Ljubimov (B38) 1996; 44 Meyers (B42) 2016; 44 Papadopoulos (B47) 2013; 14 Gundersen (B17) 2014; 219 Gao (B14) 2019; 221 Jing (B30) 2014; 127 Li (B32) 2024; 250 Tokhi (B66) 2023; 14 Yang (B84) 2021; 101 Wang (B72) 2021; 759 Mestre (B41) 2018; 7 Ren (B50) 2021; 56 Seifert (B53) 2006; 7 Wei (B76) 2017; 182 |
References_xml | – volume: 34 start-page: 190 year: 2023 ident: B80 article-title: Restoration of aquaporin-4 polarization in the spinal glymphatic system by metformin in rats with painful diabetic neuropathy publication-title: Neuroreport doi: 10.1097/wnr.0000000000001880 contributor: fullname: Xu – volume: 31 start-page: 249 year: 2009 ident: B27 article-title: Experimental rodent models of type 2 diabetes: a review publication-title: Methods Find. Exp. Clin. Pharmacol. doi: 10.1358/mf.2009.31.4.1362513 contributor: fullname: Islam – volume: 37 start-page: 1326 year: 2017 ident: B29 article-title: Impairment of the glymphatic system after diabetes publication-title: J. Cereb. Blood Flow. Metab. doi: 10.1177/0271678x16654702 contributor: fullname: Jiang – volume: 161 start-page: 639 year: 2014 ident: B16 article-title: Pharmacologic interventions for painful diabetic neuropathy: an umbrella systematic review and comparative effectiveness network meta-analysis publication-title: Ann. Intern Med. doi: 10.7326/m14-0511 contributor: fullname: Griebeler – volume: 34 start-page: 2220 year: 2011 ident: B1 article-title: Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K publication-title: Diabetes Care doi: 10.2337/dc11-1108 contributor: fullname: Abbott – volume: 250 start-page: 109907 year: 2024 ident: B32 article-title: Ginkgolide B can alleviate spinal cord glymphatic system dysfunction and provide neuroprotection in painful diabetic neuropathy rats by inhibiting matrix metalloproteinase-9 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2024.109907 contributor: fullname: Li – volume: 100 start-page: 1908 ident: B70 article-title: Plasticity of the spinal glymphatic system in male SD rats with painful diabetic neuropathy induced by type 2 diabetes mellitus publication-title: J. Neurosci. Res. doi: 10.1002/jnr.25104 contributor: fullname: Wang – volume: 15 start-page: 13 year: 2018 ident: B35 article-title: Fluid outflow in the rat spinal cord: the role of perivascular and paravascular pathways publication-title: Fluids Barriers CNS doi: 10.1186/s12987-018-0098-1 contributor: fullname: Liu – volume: 127 start-page: 2808 year: 2014 ident: B30 article-title: Microvascular protective role of pericytes in melatonin-treated spinal cord injury in the C57BL/6 mice publication-title: Chin. Med. J. Engl. contributor: fullname: Jing – volume: 21 start-page: 1161 year: 2017 ident: B68 article-title: The aquaporin-4 water channel as a potential drug target in neurological disorders publication-title: Expert Opin. Ther. Targets doi: 10.1080/14728222.2017.1398236 contributor: fullname: Verkman – volume: 10 start-page: 1019 year: 2019 ident: B39 article-title: Elevated levels of NLRP3 in cerebrospinal fluid of patients with autoimmune GFAP astrocytopathy publication-title: Front. Neurol. doi: 10.3389/fneur.2019.01019 contributor: fullname: Luo – volume: 44 start-page: 1469 year: 1996 ident: B38 article-title: Basement membrane abnormalities in human eyes with diabetic retinopathy publication-title: J. Histochem Cytochem doi: 10.1177/44.12.8985139 contributor: fullname: Ljubimov – volume: 95 start-page: 186 ident: B89 article-title: Neuroprotective effect of liquiritin against neuropathic pain induced by chronic constriction injury of the sciatic nerve in mice publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2017.07.167 contributor: fullname: Zhang – volume: 351 start-page: 577457 year: 2021 ident: B79 article-title: LncRNA NEAT1/miR-128-3p/AQP4 axis regulating spinal cord injury-induced neuropathic pain progression publication-title: J. Neuroimmunol. doi: 10.1016/j.jneuroim.2020.577457 contributor: fullname: Xian – volume: 801 start-page: 137164 year: 2023 ident: B54 article-title: Sevoflurane preconditioning improves neuroinflammation in cerebral ischemia/reperfusion induced rats through ROS-NLRP3 pathway publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2023.137164 contributor: fullname: Shang – volume: 9 start-page: e13290 ident: B73 article-title: Liquiritin inhibits MRGPRX2-mediated pseudo-allergy through the PI3K/AKT and PLCγ signaling pathways publication-title: Heliyon doi: 10.1016/j.heliyon.2023.e13290 contributor: fullname: Wang – volume: 287 start-page: 1 year: 2011 ident: B77 article-title: Structure and functions of aquaporin-4-based orthogonal arrays of particles publication-title: Int. Rev. Cell Mol. Biol. doi: 10.1016/b978-0-12-386043-9.00001-3 contributor: fullname: Wolburg – volume: 10 start-page: 2261 year: 2022 ident: B6 article-title: The role of glymphatic system in Alzheimer's and Parkinson's disease pathogenesis publication-title: Biomedicines doi: 10.3390/biomedicines10092261 contributor: fullname: Buccellato – volume: 11 start-page: 978 year: 2020 ident: B49 article-title: Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation publication-title: Cell Death Dis. doi: 10.1038/s41419-020-03178-2 contributor: fullname: Peng – volume: 56 start-page: 840 year: 2021 ident: B50 article-title: NLRP3 inflammasome mediates neurodegeneration in rats with chronic neuropathic pain publication-title: Shock doi: 10.1097/shk.0000000000001832 contributor: fullname: Ren – volume: 7 start-page: 194 year: 2006 ident: B53 article-title: Astrocyte dysfunction in neurological disorders: a molecular perspective publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn1870 contributor: fullname: Seifert – volume: 10 start-page: 1522 year: 2019 ident: B57 article-title: Inhibitory effects of columbianadin on nociceptive behaviors in a neuropathic pain model, and on voltage-gated calcium currents in dorsal root ganglion neurons in mice publication-title: Front. Pharmacol. doi: 10.3389/fphar.2019.01522 contributor: fullname: Su – volume: 283 start-page: 85 year: 2016 ident: B22 article-title: Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2016.05.003 contributor: fullname: Hubbard – volume: 27 start-page: 629 year: 2011 ident: B64 article-title: Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management publication-title: Diabetes Metab. Res. Rev. doi: 10.1002/dmrr.1225 contributor: fullname: Tesfaye – volume: 759 start-page: 136049 year: 2021 ident: B72 article-title: Enterovirus 71 infection induced Aquaporin-4 depolarization by increasing matrix metalloproteinase-9 activity publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2021.136049 contributor: fullname: Wang – volume: 149 start-page: 104803 year: 2021 ident: B9 article-title: Recent advances in chemical analysis of licorice (Gan-Cao) publication-title: Fitoterapia doi: 10.1016/j.fitote.2020.104803 contributor: fullname: Cheng – volume: 219 start-page: 2181 year: 2014 ident: B17 article-title: Evidence that pericytes regulate aquaporin-4 polarization in mouse cortical astrocytes publication-title: Brain Struct. Funct. doi: 10.1007/s00429-013-0629-0 contributor: fullname: Gundersen – volume: 66 start-page: 8 year: 2012 ident: B45 article-title: Comparison of manual and automated filaments for evaluation of neuropathic pain behavior in rats publication-title: J. Pharmacol. Toxicol. Methods doi: 10.1016/j.vascn.2012.04.006 contributor: fullname: Nirogi – volume: 13 start-page: 944386 year: 2022 ident: B8 article-title: Combination of paeoniflorin and liquiritin alleviates neuropathic pain by lipid metabolism and calcium signaling coordination publication-title: Front. Pharmacol. doi: 10.3389/fphar.2022.944386 contributor: fullname: Chen – volume: 147 start-page: 100 year: 2024 ident: B37 article-title: Glymphatic dysfunction in patients with early-stage amyotrophic lateral sclerosis publication-title: Brain doi: 10.1093/brain/awad274 contributor: fullname: Liu – volume: 76 start-page: 845 year: 2014 ident: B31 article-title: Impairment of paravascular clearance pathways in the aging brain publication-title: Ann. Neurol. doi: 10.1002/ana.24271 contributor: fullname: Kress – volume: 7 start-page: e40070 year: 2018 ident: B41 article-title: Aquaporin-4-dependent glymphatic solute transport in the rodent brain publication-title: Elife doi: 10.7554/eLife.40070 contributor: fullname: Mestre – volume: 286 start-page: 120062 year: 2021 ident: B36 article-title: A new mouse model of type 2 diabetes mellitus established through combination of high-fat diet, streptozotocin and glucocorticoid publication-title: Life Sci. doi: 10.1016/j.lfs.2021.120062 contributor: fullname: Liu – volume: 16 start-page: 1739 year: 2017 ident: B10 article-title: Alterations in AQP4 expression and polarization in the course of motor neuron degeneration in SOD1G93A mice publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2017.6786 contributor: fullname: Dai – volume: 44 start-page: 296 year: 2016 ident: B42 article-title: Does hydration status affect MRI measures of brain volume or water content? publication-title: J. Magn. Reson Imaging doi: 10.1002/jmri.25168 contributor: fullname: Meyers – volume: 56 start-page: 125 year: 2024 ident: B55 article-title: Matrix metalloproteinase-9 inhibition prevents aquaporin-4 depolarization-mediated glymphatic dysfunction in Parkinson's disease publication-title: J. Adv. Res. doi: 10.1016/j.jare.2023.03.004 contributor: fullname: Si – volume: 262 start-page: 35 year: 2013 ident: B95 article-title: Minocycline influences the anti-inflammatory interleukins and enhances the effectiveness of morphine under mice diabetic neuropathy publication-title: J. Neuroimmunol. doi: 10.1016/j.jneuroim.2013.06.005 contributor: fullname: Zychowska – volume: 220 start-page: 237 year: 2012 ident: B11 article-title: Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocyte activation, inflammation, and altered expression of channels and receptors publication-title: Neuroscience doi: 10.1016/j.neuroscience.2012.06.002 contributor: fullname: Das – volume: 34 start-page: 16180 year: 2014 ident: B23 article-title: Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury publication-title: J. Neurosci. doi: 10.1523/jneurosci.3020-14.2014 contributor: fullname: Iliff – volume: 7 start-page: 36 year: 2010 ident: B61 article-title: Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy publication-title: J. Neuroinflammation doi: 10.1186/1742-2094-7-36 contributor: fullname: Talbot – volume: 16 start-page: 4111 year: 2022 ident: B20 article-title: Liquiritin protects against cardiac fibrosis after myocardial infarction by inhibiting CCL5 expression and the NF-κB signaling pathway publication-title: Drug Des. Devel Ther. doi: 10.2147/dddt.S386805 contributor: fullname: Han – volume: 4 start-page: 147ra111 year: 2012 ident: B25 article-title: A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3003748 contributor: fullname: Iliff – volume: 14 start-page: 17 year: 2020 ident: B67 article-title: Perivascular unit: this must Be the place. The anatomical crossroad between the immune, vascular and nervous system publication-title: Front. Neuroanat. doi: 10.3389/fnana.2020.00017 contributor: fullname: Troili – volume: 186 start-page: 109806 year: 2022 ident: B90 article-title: Glucagon-like peptide-1 receptor agonist attenuates diabetic neuropathic pain via inhibition of NOD-like receptor protein 3 inflammasome in brain microglia publication-title: Diabetes Res. Clin. Pract. doi: 10.1016/j.diabres.2022.109806 contributor: fullname: Zhang – volume: 7 start-page: 69 year: 2014 ident: B34 article-title: Sevoflurane preconditioning ameliorates neuronal deficits by inhibiting microglial MMP-9 expression after spinal cord ischemia/reperfusion in rats publication-title: Mol. Brain doi: 10.1186/s13041-014-0069-7 contributor: fullname: Li – volume: 14 start-page: 265 year: 2013 ident: B47 article-title: Aquaporin water channels in the nervous system publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn3468 contributor: fullname: Papadopoulos – volume: 183 start-page: 109119 year: 2022 ident: B58 article-title: IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 publication-title: Diabetes Res. Clin. Pract. doi: 10.1016/j.diabres.2021.109119 contributor: fullname: Sun – volume: 17 start-page: 1413 year: 2016 ident: B62 article-title: Aquaporin-4: a potential therapeutic target for cerebral edema publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms17101413 contributor: fullname: Tang – volume: 16 start-page: 926128 ident: B69 article-title: β-Hydroxybutyrate attenuates painful diabetic neuropathy via restoration of the aquaporin-4 polarity in the spinal glymphatic system publication-title: Front. Neurosci. doi: 10.3389/fnins.2022.926128 contributor: fullname: Wang – volume: 40 start-page: 2583 year: 2015 ident: B28 article-title: The glymphatic system: a beginner's guide publication-title: Neurochem. Res. doi: 10.1007/s11064-015-1581-6 contributor: fullname: Jessen – volume: 138 start-page: 191 year: 2023 ident: B81 article-title: Activation of the NLRP3/IL-1β/MMP-9 pathway and intracranial aneurysm rupture associated with the depletion of ERα and Sirt1 in oophorectomized rats publication-title: J. Neurosurg. doi: 10.3171/2022.4.Jns212945 contributor: fullname: Yamaguchi – volume: 10 start-page: 395 ident: B88 article-title: Intermittent fasting protects against Alzheimer's disease possible through restoring aquaporin-4 polarity publication-title: Front. Mol. Neurosci. doi: 10.3389/fnmol.2017.00395 contributor: fullname: Zhang – volume: 11 start-page: 436 year: 2020 ident: B43 article-title: Liquiritin alleviates pain through inhibiting CXCL1/CXCR2 signaling pathway in bone cancer pain rat publication-title: Front. Pharmacol. doi: 10.3389/fphar.2020.00436 contributor: fullname: Ni – volume: 22 start-page: 67 year: 2021 ident: B3 article-title: Clinical profile and incidence of microvascular complications of childhood and adolescent onset type 1 and type 2 diabetes seen at a tertiary diabetes center in India publication-title: Pediatr. Diabetes doi: 10.1111/pedi.13033 contributor: fullname: Amutha – volume: 123 start-page: 1299 ident: B24 article-title: Brain-wide pathway for waste clearance captured by contrast-enhanced MRI publication-title: J. Clin. Invest. doi: 10.1172/jci67677 contributor: fullname: Iliff – volume: 49 start-page: 406 year: 2012 ident: B83 article-title: Aquaporin-4 mediates astrocyte response to β-amyloid publication-title: Mol. Cell Neurosci. doi: 10.1016/j.mcn.2012.02.002 contributor: fullname: Yang – volume: 111 start-page: 2083 ident: B74 article-title: Liquiritin-hydroxypropyl-beta-cyclodextrin inclusion complex: preparation, characterization, bioavailability and antitumor activity evaluation publication-title: J. Pharm. Sci. doi: 10.1016/j.xphs.2022.03.021 contributor: fullname: Wang – volume: 326 start-page: 141 year: 2016 ident: B82 article-title: β-Dystroglycan cleavage by matrix metalloproteinase-2/-9 disturbs aquaporin-4 polarization and influences brain edema in acute cerebral ischemia publication-title: Neuroscience doi: 10.1016/j.neuroscience.2016.03.055 contributor: fullname: Yan – volume: 1 start-page: e78 year: 2021 ident: B13 article-title: Streptozotocin-induced diabetic models in mice and rats publication-title: Curr. Protoc. doi: 10.1002/cpz1.78 contributor: fullname: Furman – volume: 153 start-page: 543 year: 2001 ident: B21 article-title: Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis publication-title: J. Cell Biol. doi: 10.1083/jcb.153.3.543 contributor: fullname: Hellström – volume: 17 start-page: 171 year: 1997 ident: B44 article-title: Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain publication-title: J. Neurosci. doi: 10.1523/jneurosci.17-01-00171.1997 contributor: fullname: Nielsen – volume: 11 start-page: e0163909 year: 2016 ident: B65 article-title: Efficacy of intrathecal morphine in a model of surgical pain in rats publication-title: PLoS One doi: 10.1371/journal.pone.0163909 contributor: fullname: Thomas – volume: 42 start-page: 1445 year: 2018 ident: B33 article-title: Liquiritin suppresses UVB-induced skin injury through prevention of inflammation, oxidative stress and apoptosis through the TLR4/MyD88/NF-κB and MAPK/caspase signaling pathways publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2018.3720 contributor: fullname: Li – volume: 182 start-page: 29 year: 2017 ident: B76 article-title: The pathway of subarachnoid CSF moving into the spinal parenchyma and the role of astrocytic aquaporin-4 in this process publication-title: Life Sci. doi: 10.1016/j.lfs.2017.05.028 contributor: fullname: Wei – volume: 33 start-page: 18190 ident: B26 article-title: Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain publication-title: J. Neurosci. doi: 10.1523/jneurosci.1592-13.2013 contributor: fullname: Iliff – volume: 13 start-page: 572 year: 2019 ident: B86 article-title: Dynamic balance of microglia and astrocytes involved in the remyelinating effect of ginkgolide B publication-title: Front. Cell Neurosci. doi: 10.3389/fncel.2019.00572 contributor: fullname: Yin – volume: 6 start-page: 159 year: 2000 ident: B40 article-title: Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke publication-title: Nat. Med. doi: 10.1038/72256 contributor: fullname: Manley – volume: 53 start-page: 55 year: 1994 ident: B7 article-title: Quantitative assessment of tactile allodynia in the rat paw publication-title: J. Neurosci. Methods doi: 10.1016/0165-0270(94)90144-9 contributor: fullname: Chaplan – volume: 73 start-page: 874 year: 2008 ident: B51 article-title: The role of estrogen receptors in the control of energy and glucose homeostasis publication-title: Steroids doi: 10.1016/j.steroids.2007.12.018 contributor: fullname: Ropero – volume: 109 start-page: 108800 year: 2022 ident: B92 article-title: Sevoflurane suppresses NLRP3 inflammasome-mediated pyroptotic cell death to attenuate lipopolysaccharide-induced acute lung injury through inducing GSK-3β phosphorylation and activation publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2022.108800 contributor: fullname: Zheng – volume: 16 start-page: 77 year: 2016 ident: B2 article-title: Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms publication-title: BMC Complement. Altern. Med. doi: 10.1186/s12906-016-1048-6 contributor: fullname: Aman – volume: 12 start-page: 605814 ident: B93 article-title: Xueshuantong improves functions of lymphatic ducts and modulates inflammatory responses in Alzheimer's disease mice publication-title: Front. Pharmacol. doi: 10.3389/fphar.2021.605814 contributor: fullname: Zheng – volume: 12 start-page: e82232 year: 2023 ident: B15 article-title: Loss of aquaporin-4 results in glymphatic system dysfunction via brain-wide interstitial fluid stagnation publication-title: Elife doi: 10.7554/eLife.82232 contributor: fullname: Gomolka – volume: 11 start-page: 1016 year: 2020 ident: B56 article-title: The NLRP3 inflammasome: role and therapeutic potential in pain treatment publication-title: Front. Physiol. doi: 10.3389/fphys.2020.01016 contributor: fullname: Starobova – volume: 416 start-page: 115468 ident: B94 article-title: Salidroside alleviates diabetic neuropathic pain through regulation of the AMPK-NLRP3 inflammasome axis publication-title: Toxicol. Appl. Pharmacol. doi: 10.1016/j.taap.2021.115468 contributor: fullname: Zheng – volume: 19 start-page: 771 year: 2016 ident: B60 article-title: Pericytes of the neurovascular unit: key functions and signaling pathways publication-title: Nat. Neurosci. doi: 10.1038/nn.4288 contributor: fullname: Sweeney – volume: 26 start-page: 1 year: 2022 ident: B63 article-title: Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT publication-title: Health Technol. Assess. doi: 10.3310/rxuo6757 contributor: fullname: Tesfaye – volume: 101 start-page: 108283 year: 2021 ident: B84 article-title: Liquiritin reduces lipopolysaccharide-aroused HaCaT cell inflammation damage via regulation of microRNA-31/MyD88 publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2021.108283 contributor: fullname: Yang – volume: 60 start-page: 867 year: 2012 ident: B19 article-title: Aquaporin-4 regulates extracellular space volume dynamics during high-frequency synaptic stimulation: a gene deletion study in mouse hippocampus publication-title: Glia doi: 10.1002/glia.22319 contributor: fullname: Haj-Yasein – volume: 9 start-page: e001847 year: 2021 ident: B4 article-title: Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes publication-title: BMJ Open Diabetes Res. Care doi: 10.1136/bmjdrc-2020-001847 contributor: fullname: An – volume: 74 start-page: 91 year: 2017 ident: B87 article-title: Association of perivascular localization of aquaporin-4 with cognition and alzheimer disease in aging brains publication-title: JAMA Neurol. doi: 10.1001/jamaneurol.2016.4370 contributor: fullname: Zeppenfeld – volume: 37 start-page: 2904 year: 2017 ident: B52 article-title: Cortical spreading depression closes paravascular space and impairs glymphatic flow: implications for migraine headache publication-title: J. Neurosci. doi: 10.1523/jneurosci.3390-16.2017 contributor: fullname: Schain – volume: 5 start-page: 3413 year: 2014 ident: B85 article-title: Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity publication-title: Nat. Commun. doi: 10.1038/ncomms4413 contributor: fullname: Yao – volume: 10 start-page: 2313 year: 2019 ident: B48 article-title: Type 2 diabetes mellitus and menopausal hormone therapy: an update publication-title: Diabetes Ther. doi: 10.1007/s13300-019-00695-y contributor: fullname: Paschou – volume: 30 start-page: 716 ident: B75 article-title: Single-cell RNA sequencing reveals changes in glioma-associated macrophage polarization and cellular states of malignant gliomas with high AQP4 expression publication-title: Cancer Gene Ther. doi: 10.1038/s41417-022-00582-y contributor: fullname: Wang – volume: 9 start-page: e107022 year: 2014 ident: B12 article-title: Expression of aquaporin 4 and breakdown of the blood-brain barrier after hypoglycemia-induced brain edema in rats publication-title: PLoS One doi: 10.1371/journal.pone.0107022 contributor: fullname: Deng – volume: 10 start-page: 542 year: 2019 ident: B59 article-title: Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome publication-title: Cell Death Dis. doi: 10.1038/s41419-019-1761-4 contributor: fullname: Sun – volume: 14 start-page: 1128496 year: 2023 ident: B66 article-title: Effects of 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline on a diabetic neuropathic pain model publication-title: Front. Pharmacol. doi: 10.3389/fphar.2023.1128496 contributor: fullname: Tokhi – volume: 22 start-page: 778 year: 2007 ident: B46 article-title: Aquaporin-4 and brain edema publication-title: Pediatr. Nephrol. doi: 10.1007/s00467-006-0411-0 contributor: fullname: Papadopoulos – volume: 251 start-page: 117638 year: 2020 ident: B71 article-title: Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion publication-title: Life Sci. doi: 10.1016/j.lfs.2020.117638 contributor: fullname: Wang – volume: 221 start-page: 143 year: 2019 ident: B14 article-title: Sevoflurane enhanced the clearance of Aβ1-40 in hippocampus under surgery via up-regulating AQP-4 expression in astrocyte publication-title: Life Sci. doi: 10.1016/j.lfs.2019.02.024 contributor: fullname: Gao – volume: 161 start-page: 574 year: 2020 ident: B18 article-title: Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross-sectional questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes publication-title: Pain doi: 10.1097/j.pain.0000000000001744 contributor: fullname: Gylfadottir – volume: 118 start-page: 219 year: 2009 ident: B78 article-title: Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis publication-title: Acta Neuropathol. doi: 10.1007/s00401-009-0558-4 contributor: fullname: Wolburg-Buchholz – volume: 12 start-page: 719758 year: 2021 ident: B91 article-title: Traditional uses, pharmacological effects, and molecular mechanisms of licorice in potential therapy of COVID-19 publication-title: Front. Pharmacol. doi: 10.3389/fphar.2021.719758 contributor: fullname: Zhang – volume: 45 start-page: 588 year: 2021 ident: B5 article-title: Prevalence and risk evaluation of diabetic complications of the foot among adults with type 1 and type 2 diabetes in a large Canadian population (PEDAL study) publication-title: Can. J. Diabetes doi: 10.1016/j.jcjd.2020.11.011 contributor: fullname: Aronson |
SSID | ssj0000399364 |
Score | 2.401974 |
Snippet | Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated a... Background Despite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated... BackgroundDespite advancements in diabetes treatment, the management of Painful Diabetic Neuropathy (PDN) remains challenging. Our previous research indicated... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 1436146 |
SubjectTerms | aquaporin-4 glymphatic system liquiritin matrix metalloproteinase-9 painful diabetic neuropathy Pharmacology |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ3JbtswEIaJIqdeiu5VN0yBIpeGiExSC4_dgqCIA6NNgNwEkiJjAY6sxvbBr9Kn7QzpJHZRoJcefJBFWwTnl_iNPfzJ2HvrjC5MGbjyLudKC8ttXQUurDUuaNXqaOI6Pi2Pz9W3i-Jia6svqglL9sBp4A4rG6SzzuVx6ka1hGrkhBV522qc2xMa5XormYrPYJp3S5VWyWAWpg_DMDXk_ykUPhxkGYl3ayaKhv1_o8w_iyW3Zp-jh-zBBhvhY-ruI3bP94_Z_iT5Tq8P4OxuGdXiAPZhcudIvX7Cfp10VPDbLbsezJWf0bJ8REwYDOprNYP0A2znILpb0ibFa8CmP74AtluApaNpZ-nzl3B68n0i-Xg84ZrHdSfIrEBGUNcL7OE8gPm5MgPV9XEFA2XOCPr0dYiacDlbo3zIJRaSh_RTdn709ezzMd9sysCdLPIld94Wgciwdh5RM7gyjDDLLZxAcAi-RjyUufG2tqgOSp4IEMIISU-WtZJePmN7_bz3LxhUVSXxJUYl5phF7bUKpnStQGKV2to2Yx9uAtQMyXujwZyFwtnEcDYUzmYTzox9ohjetiTf7PgGqqnZqKn5l5oy9u5GAQ3eZ_Tnien9fLVoJHntIa1qkbHnSRG3lyLGLLSSGat3tLLTl90zfTeNXt6YjuLQCPnyf_T-FbtPIxJL4NRrtre8Xvk3yExL-zbeHr8BW_MYDw priority: 102 providerName: Directory of Open Access Journals |
Title | Liquiritin ameliorates painful diabetic neuropathy in SD rats by inhibiting NLRP3-MMP-9-mediated reversal of aquaporin-4 polarity in the glymphatic system |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39295943 https://www.proquest.com/docview/3106735292 https://pubmed.ncbi.nlm.nih.gov/PMC11408323 https://doaj.org/article/7bf3cbcc042644638f71c2b20dd9392a |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3JbtswEIaJJKdeiu5Vl4AFilwaxjJJLTy2aYOgiAOhTYDcBJIibQG2rHo5-FX6tJ2hrMQueurBB9uUTXh-kd_IM78I-WisVolOPZPOxkwqbpjJM8-4Mdp6JSsVTFxH1-nlrfx-l9wdkLTvhQlF-9bUZ810dtbUk1Bb2c7soK8TGxSjc2B4IAcuBofkEBS6k6OH9Rf33FR2HTKQgamBbycavT-5hIVBpIF2d3ahYNb_L8L8u1ByZ-e5eEIeb5GRfu6m9pQcuOYZOSk6z-nNKb15aKFantITWjy4UW-ek99XNRb71qu6oXrmptiSD3hJWw3aWk9pd_G1tjQ4W-INijcUhv78SmHckhp8NqkNHj-m11c_CsFGo4IpFnpOgFcpmkAtljDDuaf611q3WNPHJG0xawbIx48DzKTj6Qakgw6xtPOPfkFuL77dnF-y7Q0ZmBVJvGLWmcQjFebWAWZ6m_ohZLiJ5QAN3uWAhiLWzuQGlIGJE8KBH0KsRJpL4cRLctTMG_ea0CzLBDz4MIX8Msmdkl6ntuJAq0IZU0XkUx-gsu18N0rIVzCcZQhnieEst-GMyBeM4f1I9MwOL8wX43KrnDIzXlhjbRwgENYdnw0tNzyuKgWUqCPyoVdACecY_nGiGzdfL0uBPntAqopH5FWniPuvQr5MlBQRyfe0sjeX_XdA1sHHu5fxm_8_9C15hL9DKHqT78jRarF274GSVuY4XF04DqfGH1ynGAs |
link.rule.ids | 230,315,730,783,787,867,888,2109,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1bk9IwFMcz6_qgL95d8RpnnH1xA6VJL3nU1R1UYBhlx33rJCGBjlAqlwf8KH5az0npLuz4og88QFNI23-S36Hn_EvIG22UjFTsmLAmYEKGmuk0cSzUWhknxUh6E9deP-6ci88X0cUBietaGJ-0b3TeLKazZpFPfG5lOTOtOk-sNeidAsMDOYS8dYPchAEbiJ0o3c_AuOrGoqqRgRhMtlw5Uej-GQqYGnjseXdnHfJ2_X9jzOupkjtrz9ld8r3udZVy8qO5Xumm-XXN0PHfD-seubPFUfqu2n6fHNjiATkeVH7WmxM6vCrPWp7QYzq4crrePCS_uzkmEuervKBqZqdY7g_oSksFul1PafXHbm6od83Ehx9vKDT99oFCuyXV-G6Sa9x_TPvdrwPOer0Bk8zXswALUzSYWiyhh3NH1c-1KjFfkAlaYkQOAQR-HSAsHU83IEt0n6WVN_Ujcn72cXjaYduHPTDDo2DFjNWRQ-JMjQWEdSZ2bYieIxMCkDibAnbyQFmdalAdBmUIHq4NJ4zHqeCWPyaHxbywTwhNkoTDK2zHELtGqZXCqdiMQiBhLrUeNcjb-tJnZeXpkUEshELJvFAyFEq2FUqDvEd1XLZEP27_wXwxzraXL0u040YbE3jAhDnNJW0T6jAYjSQQqGqQ17W2Mhi_eFNGFXa-XmYcPfyAgmXYIEeV1i5_Ctk1koI3SLqnwr2-7G8BbXmP8FpLT_9_11fkVmfY62bdT_0vz8htPCc-uU48J4erxdq-ABpb6Zd-6P0Bo045Mw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1bb9MwFMctGBLihXEd5WoktBeWNo2dix9hoxrQVhFs0iQeItux24g2zXp5KB-FT8s5Trq1E0976EMaJ3GSv-3fSY7_IeSD0lKEMrIeN9r3uAiUp5LYeoFSUlvBc-FMXAfD6PScf7sIL5qsykWTVllqVbTLybRdFmOXW1lNdWeTJ9ZJB8fA8EAOAetUue3cJfeg0frRVqTuemEceSNez5OBOEx0bDWW6AAacOgeWOSYd2sscpb9_-PMm-mSW-NPb5_82tS8Tjv53V4tVVv_uWHqeLtTe0QeNlhKP9VlHpM7pnxCDtPa13p9RM-up2ktjughTa8dr9dPyd9-gQnFxbIoqZyaCU77B4SllQT9ria0fsBbaOrcM_EjyGsKRX-eUCi3oAqXxoXC7Ud02P-RMm8wSD3huXktwMQUjabmC6jhzFJ5uZIV5g16nFYYmUMggbsDlKWjyRrkiS60tPaofkbOe1_Ojk-95qMPnmahv_S0UaFF8ky0AZS1OrJdiKJDHQCYWJMAfjJfGpUoUB8GZwggtgsXjUUJZ4Y9J3vlrDQvCI3jmMEv6EYQw4aJEdzKSOcBEDETSuUt8nFz-7Oq9vbIICZCsWROLBmKJWvE0iKfUSFXJdGX2_0xm4-y5hZmsbJMK619B5rQt9m4qwMV-HkugERli7zf6CuDdowvZ2RpZqtFxtDLD2hYBC1yUOvt6lDIsKHgrEWSHSXu1GV3DejLeYVv9PTy9pu-I_fTk17W_zr8_oo8wEvicuz4a7K3nK_MG4CypXrrWt8_SJo7sw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Liquiritin+ameliorates+painful+diabetic+neuropathy+in+SD+rats+by+inhibiting+NLRP3-MMP-9-mediated+reversal+of+aquaporin-4+polarity+in+the+glymphatic+system&rft.jtitle=Frontiers+in+pharmacology&rft.au=Jia%2C+Shuai-Ying&rft.au=Yin%2C+Wen-Qin&rft.au=Xu%2C+Wen-Mei&rft.au=Li%2C+Jiang&rft.date=2024-09-04&rft.issn=1663-9812&rft.eissn=1663-9812&rft.volume=15&rft.spage=1436146&rft_id=info:doi/10.3389%2Ffphar.2024.1436146&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |